144 related articles for article (PubMed ID: 37148805)
1. Craniofacial involvement in Langerhans cell histiocytosis: A review of 44 cases at a single medical center.
Lin TE; Chu YY; Chang TY; Liao HT
J Plast Reconstr Aesthet Surg; 2023 Jul; 82():12-20. PubMed ID: 37148805
[TBL] [Abstract][Full Text] [Related]
2. Langerhans cell histiocytosis of the temporal bone: A review of 29 cases at a single center.
Modest MC; Garcia JJ; Arndt CS; Carlson ML
Laryngoscope; 2016 Aug; 126(8):1899-904. PubMed ID: 26535795
[TBL] [Abstract][Full Text] [Related]
3. Pediatric langerhans cell histiocytosis: single center experience over a 17-year period.
İnce D; Demirağ B; Özek G; Erbay A; Ortaç R; Oymak Y; Kamer S; Yaman Y; Kundak S; Vergin C
Turk J Pediatr; 2016; 58(4):349-355. PubMed ID: 28276205
[TBL] [Abstract][Full Text] [Related]
4. Childhood Langerhans cell histiocytosis: a disease with many faces.
Leung AKC; Lam JM; Leong KF
World J Pediatr; 2019 Dec; 15(6):536-545. PubMed ID: 31456157
[TBL] [Abstract][Full Text] [Related]
5. Langerhans' cell histiocytosis of the temporal bone in children.
Saliba I; Sidani K; El Fata F; Arcand P; Quintal MC; Abela A
Int J Pediatr Otorhinolaryngol; 2008 Jun; 72(6):775-86. PubMed ID: 18355926
[TBL] [Abstract][Full Text] [Related]
6. Clinical and prognostic characteristics of 95 cases of Langerhans cell histiocytosis in children: a single-institute experience from 2013 to 2020.
Tang X; Gao J; Ma ZG; Guo X; Li Q; Wan Z; Sun JJ
Ann Med; 2021 Dec; 53(1):1537-1546. PubMed ID: 34459688
[TBL] [Abstract][Full Text] [Related]
7. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group.
Haupt R; Nanduri V; Calevo MG; Bernstrand C; Braier JL; Broadbent V; Rey G; McClain KL; Janka-Schaub G; Egeler RM
Pediatr Blood Cancer; 2004 May; 42(5):438-44. PubMed ID: 15049016
[TBL] [Abstract][Full Text] [Related]
8. Bone lesions of Langerhans cell histiocytosis triggered by trauma in children.
Morimoto A; Shioda Y; Sakamoto K; Imamura T; Imashuku S;
Pediatr Int; 2022 Jan; 64(1):e15199. PubMed ID: 35770832
[TBL] [Abstract][Full Text] [Related]
9. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S;
Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922
[TBL] [Abstract][Full Text] [Related]
10. Clinical Analysis of 122 Cases of Langerhans Cell Histiocytosis.
Wang T; Su B; Han D; Tong A; Li J; Liu Y; Jin H; Fang K
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Apr; 39(2):206-210. PubMed ID: 28483018
[TBL] [Abstract][Full Text] [Related]
11. Outcome of children with Langerhans cell histiocytosis and single-system involvement: A retrospective study at a single center in Shanghai, China.
Su M; Gao YJ; Pan C; Chen J; Tang JY
Pediatr Hematol Oncol; 2018; 35(7-8):385-392. PubMed ID: 30693828
[TBL] [Abstract][Full Text] [Related]
12. Pediatric Langerhans cell histiocytosis of the lateral skull base.
Majumder A; Wick CC; Collins R; Booth TN; Isaacson B; Kutz JW
Int J Pediatr Otorhinolaryngol; 2017 Aug; 99():135-140. PubMed ID: 28688556
[TBL] [Abstract][Full Text] [Related]
13. Langerhans cell histiocytosis in adults: a retrospective, single-center case series.
Chiaravalli S; Ferrari A; Bergamaschi L; Puma N; Gattuso G; Sironi G; Nigro O; Livellara V; Schiavello E; Biassoni V; Podda M; Meazza C; Spreafico F; Casanova M; Terenziani M; Luksch R; Massimino M
Ann Hematol; 2022 Feb; 101(2):265-272. PubMed ID: 34635964
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes and prognostic factors of patients with adult Langerhans cell histiocytosis.
Cao XX; Duan MH; Zhao AL; Cai H; Chen J; Gao XM; Liu T; Cai HC; Zhang L; Sun J; Liang ZY; Zhou DB; Li J
Am J Hematol; 2022 Feb; 97(2):203-208. PubMed ID: 34797941
[TBL] [Abstract][Full Text] [Related]
15. Langerhans cell histiocytosis of skull: a retrospective study of 18 cases.
Zhang XH; Zhang J; Chen ZH; Sai K; Chen YS; Wang J; Ke C; Guo CC; Chen ZP; Mou YG
Ann Palliat Med; 2017 Apr; 6(2):159-164. PubMed ID: 28061539
[TBL] [Abstract][Full Text] [Related]
16. Head and Neck Langerhans Cell Histiocytosis in Children.
Xu J; Gilbert JR; Sutton KS; Goudy SL; Abramowicz S
J Oral Maxillofac Surg; 2022 Mar; 80(3):545-552. PubMed ID: 34852246
[TBL] [Abstract][Full Text] [Related]
17. Multisystem Langerhans cell histiocytosis in children: current treatment and future directions.
Minkov M
Paediatr Drugs; 2011 Apr; 13(2):75-86. PubMed ID: 21351807
[TBL] [Abstract][Full Text] [Related]
18. Skeletal Langerhans cell histiocytosis in children: permanent consequences and health-related quality of life in long-term survivors.
Lau LM; Stuurman K; Weitzman S
Pediatr Blood Cancer; 2008 Mar; 50(3):607-12. PubMed ID: 17973322
[TBL] [Abstract][Full Text] [Related]
19. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for diabetes insipidus in langerhans cell histiocytosis.
Grois N; Pötschger U; Prosch H; Minkov M; Arico M; Braier J; Henter JI; Janka-Schaub G; Ladisch S; Ritter J; Steiner M; Unger E; Gadner H;
Pediatr Blood Cancer; 2006 Feb; 46(2):228-33. PubMed ID: 16047354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]